Institutional investors control 35.49% of the outstanding shares in MSTX. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended September 2013, these large investors purchased a net $12.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FRANKLIN ADVISERS, INC. Bought 1.1 Million shares of Mast Therapeutics Inc
DEUTSCHE BANK SECURITIES, INC. Bought 600.0 Thousand shares of Mast Therapeutics Inc
MORGAN STANLEY & CO. LLC Bought 573.6 Thousand shares of Mast Therapeutics Inc